- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Mometasone Furoate 0.1% Topical Lotion-Test product 1
Total 88 results
-
IPCA Laboratories Ltd.Completed
-
Kamari Pharma LtdRecruiting
-
Pharmtechnology LLCAltasciences Company, Inc.Unknown
-
Cipla Ltd.Not yet recruitingBronchial AsthmaUnited States
-
Johns Hopkins UniversityTerminated
-
Alcon ResearchCompletedOcular Hypertension | Glaucoma
-
Kamari Pharma LtdRecruitingPachyonychia Congenita | Punctate Palmoplantar Keratoderma Type 1United Kingdom
-
East Suburban Ob GynUnknownFemale Sexual DysfunctionUnited States
-
Lipidor ABRecruitingMild to Moderate PsoriasisIndia
-
GlaxoSmithKlinePiramal Clinical Research (Hyderabad, India)Completed
-
ALK-Abelló A/SCompletedAllergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
-
British Columbia Cancer AgencyHoffmann-La RocheCompleted
-
IPCA Laboratories Ltd.Completed
-
Lumbini Medical CollegeCompletedOtitis Media With EffusionNepal
-
CONRADCompletedHIV PreventionUnited States
-
Luigi RondasEuropean Society of Cataract and Refractive SurgeonsRecruitingEye Diseases | Macular Edema | Cataract | Lens Diseases | Retinal Disease | Cystoid Macular EdemaNetherlands, Austria, Germany, Portugal
-
GlaxoSmithKlineCompleted
-
Universiti Kebangsaan Malaysia Medical CentreInstitue of Microengineering and Nanoelectronics (IMEN), Universiti Kebangsaan... and other collaboratorsCompletedThalassemia in ChildrenMalaysia
-
NovoBliss Research Pvt LtdNanobrid Innovations Private LimitedNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer ResearchCompleted
-
Dar El Oyoun HospitalUnknownCataract | Adverse Drug Event | MydriasisEgypt
-
University of SydneyNorthern Care Alliance NHS Foundation Trust; Waitemata District Health Board; Australasian Kidney Trials NetworkRecruiting
-
University of WashingtonBayerTerminatedNon-Hodgkin's Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Grade 3b Follicular LymphomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARAUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
University Hospital, GenevaCompletedKeratitis; Infectious Disease (Manifestation)Switzerland
-
M.D. Anderson Cancer CenterRecruitingRecurrent Adult Lymphoblastic Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic Leukemia | Refractory Lymphoblastic LymphomaUnited States
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV InfectionsUnited States, Puerto Rico, Thailand, Botswana, Argentina, Brazil, Tanzania, South Africa
-
Memorial Sloan Kettering Cancer CenterCompletedNon-Hodgkin's Lymphoma | CNS Lymphoma | CNS Brain CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome NegativeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Adult Lymphoblastic Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult T Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Adult L1 Acute Lymphoblastic Leukemia | Adult L2 Acute Lymphoblastic...United States
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Not yet recruitingMetastatic Sarcoma | Resectable Sarcoma | Recurrent SarcomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedLocally Advanced SarcomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel
-
National Cancer Institute (NCI)RecruitingRenal Pelvis and Ureter Urothelial CarcinomaUnited States